Novel Psychoactive Substances and legislative harmonization in Europe: addressing a extremely elusive public health threat

Main Article Content

Federica Umani Ronchi
Department of Anatomical, Histological, Medicolegal and Orthopedic Sciences, University of Rome "Sapienza", Rome, Italy

Keywords

Novel Psychoactive Substances (NPS), Drug enforcement, EU legislative frameworks

Downloads

Download data is not yet available.
Abstract 75 | PDF Downloads 47

References

1.Mannocchi G, Di Trana A, Tini A, et al. Development and validation of fast UHPLC-MS/MS screening method for 87 NPS and 32 other drugs of abuse in hair and nails: application to real cases. Anal Bioanal Chem. 2020 Aug;412(21):5125-5145.
2.Marchei E, Tini A, Pirani F, Lo Faro AF, Marinelli S. Is GHB-glucuronide useful as a biomarker for the exogenous use of GHB? Eur Rev Med Pharmacol Sci. 2019 Mar;23(6):2311-2313. 
3.Marinelli S, Berretta P, Pacifici R, Del Rio A. Sex enhancers: challenges, threats and the need for targeted measures. Clin Ter. 2019 May-Jun;170(3):e181-e183.
4.Negro F, Di Trana A, Marinelli S. The effects of the COVID-19 pandemic on the use of the performance-enhancing drugs. Acta Biomed. 2022 Jan 19;92(6):e2021401.
5.The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). Legal approaches to controlling new psychoactive substances. Updated on 31st May 2016. Available online: https://www.emcdda.europa.eu/system/files/publications/2746/att_211257_EN_EMCDDA_POD_2013_Controlling%20new%20psychoactive%20substances.pdf (Accessed on 19th January 2023).
6.The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). New psychoactive substances: global markets, glocal threats and the COVID-19 pandemic. An update from the EU Early Warning System December 2020. Available online: https://www.emcdda.europa.eu/system/files/publications/13464/20205648_TD0320796ENN_PDF_rev.pdf (Accessed on 19th January 2023).

Article Sidebar

PDF
Published
Feb 13, 2023
DOI https://doi.org/10.23750/abm.v94i1.14194

Article Details

How to Cite

1.
Umani Ronchi F. Novel Psychoactive Substances and legislative harmonization in Europe: addressing a extremely elusive public health threat. Acta Biomed [Internet]. 2023 Feb. 13 [cited 2023 Mar. 20];94(1):e2023005. Available from: https://mattioli1885journals.com/index.php/actabiomedica/article/view/14194
Issue
Vol. 94 No. 1 (2023)
Section
LETTERS TO EDITOR
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Transfer of Copyright and Permission to Reproduce Parts of Published Papers. 
Authors retain the copyright for their published work. No formal permission will be required to reproduce parts (tables or illustrations) of published papers, provided the source is quoted appropriately and reproduction has no commercial intent. Reproductions with commercial intent will require written permission and payment of royalties.

 

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.